1. Context
Christine VAUTHIER: Director of Research at the CNRS, and researcher at the Physicochemistry-pharmacotechnics and biopharmacy laboratory, UMR CNRS 8612, Faculty of Pharmacy, Chatenay-Malabry.
Patrick COUVREUR: Professor at the University of Paris Sud, and Director of the Physicochemistry-Pharmacotechnics and Biopharmacy Laboratory, UMR CNRS 8612, Faculty of Pharmacy, Chatenay-Malabry.
Nanotechnologies have only been recognized as fully-fledged biomedical technologies for the past ten years. Yet they have been the subject of intense research for over thirty years. Indeed, the discovery of liposomes in 1965 by Bangham and the development of manufacturing methods for nanoparticles made of synthetic polymers that can be used in vivo in the late 1970s. , have paved...
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed? Log in!
Context
Designing nanotechnology tools for therapeutic and diagnostic applications
Article included in this offer
"Healthcare technologies"
(
125 articles
)
Updated and enriched with articles validated by our scientific committees
A set of exclusive tools to complement the resources
Also in our database
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed? Log in!
